 |
OIS Podcast | Ophthalmology's leading PodcastAuthor: OIS Podcast
Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009. Language: en-us Genres: Business, Entrepreneurship, Investing Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Trial by Fire: Designing and Executing Ophthalmic Studies That Deliver
Episode 431
Tuesday, 7 July, 2026
PANELIST (TITLE and AFFILIATION): Richard L. Beckman, M.D., Principal, RLB, M.D. Consulting, LLC Malvina Eydelman, M.D., CEO, The Collaborative Community on Ophthalmic Innovation MODERATOR: Barbara Wirostko, M.D., FARVO, CMO and Co-Founder, Qlaris Bio Description:How should you design your first-in-human study? Richard L. Beckman, M.D., principal of RLB, M.D. Consulting, LLC, and Malvina Eydelman, M.D., CEO of the Collaborative Community on Ophthalmic Innovation, sit down on a panel at OIS Ignite 2025, moderated by Barbara Wirostko, M.D., FARVO, CMO and co-founder, Qlaris Bio, to discuss what goes into designing first-in-human studies, including the preclinical work, the right people to advise you, and considering the population and patients. Also, stay tuned for updates on the next OIS Ignite, taking place on March 2027! In this episode, learn about: How the FDA can help and if it’s ever “too early” to reach out to them The FDA’s perspective Establishing a target product profile If a DSMB is recommended for trials RESOURCES: Barbara Wirostko: https://ois.net/barbara-wirostko-md-farvo/ Richard L. Beckman: https://ois.net/richard-rick-l-beckman-md/ Malvina Eydelman: https://ois.net/malvina-eydelman/
